These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32305638)

  • 1. Ashwagandha in brain disorders: A review of recent developments.
    Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S
    J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
    Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
    J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
    Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
    J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative diseases and Withania somnifera (L.): An update.
    Dar NJ; Muzamil Ahmad
    J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
    Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
    J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.
    Kuboyama T; Tohda C; Komatsu K
    Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
    Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
    Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
    J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents.
    Yenisetti SC; Manjunath MJ; Muralidhara C
    Recent Pat CNS Drug Discov; 2016; 10(2):204-215. PubMed ID: 27316579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated review on phytochemistry and molecular targets of
    Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
    Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
    [No Abstract]   [Full Text] [Related]  

  • 11. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
    Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A
    Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keeping abreast about ashwagandha in breast cancer.
    Vashi R; Patel BM; Goyal RK
    J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Syed AA; Reza MI; Singh P; Thombre GK; Gayen JR
    Curr Drug Metab; 2021; 22(7):561-571. PubMed ID: 33538666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing.
    Joshi VK; Joshi A
    J Ethnopharmacol; 2021 Aug; 276():114101. PubMed ID: 33831467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
    Namdeo AG; Ingawale DK
    J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
    Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
    Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Authentication of the market samples of Ashwagandha by DNA barcoding reveals that powders are significantly more adulterated than roots.
    Amritha N; Bhooma V; Parani M
    J Ethnopharmacol; 2020 Jun; 256():112725. PubMed ID: 32126246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Evaluation of Unani Medicine, Including Single Drugs and Polyherbal Formulations with Special Reference to Neurodegenerative Disorders.
    Imran S; Ahmad W; Saltanat S
    Altern Ther Health Med; 2024 Sep; 30(9):54-64. PubMed ID: 39212516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain.
    Schliebs R; Liebmann A; Bhattacharya SK; Kumar A; Ghosal S; Bigl V
    Neurochem Int; 1997 Feb; 30(2):181-90. PubMed ID: 9017665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.